Demographic, Clinical, Therapeutic and Evolutionary Features of Cataract in North-African Diabetic Population

Main Article Content

. Elkhoyaali


Background: Cataract is the leading cause of reversible blindness in the world and its treatment is the most common surgery in ophthalmology. Compared to the non-diabetic populations, cataract occurs earlier and more frequently in patients suffering from diabetes mellitus necessitating urgent operation to avoid a multitude of problems including the correction of the visual impairment as well as the accessibility of fundus examination to look after diabetic retinopathy and treat this latter by photocoagulation.

Aim: This study aims to highlight the difference of socio-demographic, clinical, therapeutic, and evolutionary features between a population of diabetic and non-diabetic patients using SPSS version 11.5 software to analyze the data.

MethodsThroughout our work, we compared the socio-demographic, clinical, therapeutic, and evolutionary characteristics between diabetic and non-diabetic populations who had received cataract surgery. It’s a retrospective study of 2,000 patients, including 672 diabetics and 1328 non-diabetics in our ophthalmology department between January and December 2019.

Results: The average age in the diabetic group is lower than non-diabetic patients (62.5 versus 66.8 years) with a masculine predominance (61.7%). Preoperative visual acuity varies from light perception to 3/10 with a predominance of total white (28.2%). We usually performed cataract surgery by phacoemulsification (94.3%) under local anesthesia (99.7%). Intraoperative complications are infrequent and comparable between the two groups (p = 0.37), but postoperative complications, dominated by secondary cataract and macular edema, are more frequent in diabetics (p = 3.10-7).

Conclusion: Mean postoperative visual acuity was lower in diabetics (8.08 versus 7.36/ p = 0) especially in subjects suffering from diabetic retinopathy.

Cataract, diabetes, phacoemulsification, retinopathy, macular edema

Article Details

How to Cite
Elkhoyaali, . (2021). Demographic, Clinical, Therapeutic and Evolutionary Features of Cataract in North-African Diabetic Population. Asian Journal of Research and Reports in Ophthalmology, 4(1), 37-44. Retrieved from
Original Research Article


Guirou N, Napo A, Dougnon A, et al. Résultats fonctionnels de la chirurgie de la cataracte de l'adulte [Visual outcome of cataract surgery in adults]. J Fr Ophtalmol. 2013;36(1):19-22. DOI:10.1016/j.jfo.2012.04.016

Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91(12):1464-1474. DOI:10.1016/s0161-6420(84)34102-1

Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol. 1983;67(4):209-213. DOI:10.1136/bjo.67.4.209

Arné JL. Chirurgie de la cataracte. Technique chirurgicale. Issy-les- Moulineaux, Masson; 2005. Site national officiel de l’assurance maladie — fond documentaire en ligne.

Jacquot F, Mohand SM, Chaine G. Diabète et chirurgie de la cataracte. EMC Ophtalmologie. 2001;21250 ;D30:10.

Malecaze F. La chirurgie de la cataracte chez le diabétique Cataract surgery in diabetics. J Fr Ophtalmol. 2003;26(5):525-527.

Ermisş SS, Oztürk F, Inan UU. Comparing the efficacy and safety of phacoemulsification in white mature and other types of senile cataracts. Br J Ophthalmol. 2003;87(11):1356-1359. DOI:10.1136/bjo.87.11.1356

Gimbel HV, Sun R, Ferensowicz M, Anderson Penno E, Kamal A. Intraoperative management of posterior capsule tears in phacoemulsification and intraocular lens implantation. Ophthalmology. 2001;108(12):2186-2192. DOI:10.1016/s0161-6420(01)00716-3

Akura J, Hatta S, Kaneda S, Ishihara M, Matsuura K, Tamai A. Management of posterior capsule rupture during phacoemulsification using the dry technique. J Cataract Refract Surg. 2001;27(7):982-989.

Lindfield R, Kuper H, Polack S, et al. Outcome of cataract surgery at one year in Kenya, the Philippines and Bangladesh. Br J Ophthalmol. 2009;93(7):875-880. DOI:10.1136/bjo.2008.152744

Bourne R, Dineen B, Jadoon Z, et al. Outcomes of cataract surgery in Pakistan: results from The Pakistan National Blindness and Visual Impairment Survey. Br J Ophthalmol. 2007;91(4):420-426.

Fanny A, Keita CT, Adjorlolo AC, Konan-Toure ML, Gbe K, Cou- libalyBerete F, et al. Accessibilité à l’intervention chirurgicale de la cataracte dans les pays en développement: Résultats de 120 cas de cataracte opérés en 6 mois au CHU de Treichville, Abidjan, Côte-d’Ivoire. Med Afr Noire. 2001;48.

Somaiya M, Burns JD, Mintz R, Warren RE, Uchida T, Godley BF. Factors affecting visual outcomes after small-incision phacoemulsification in diabetic patients. J Cataract Refract Surg. 2002;28(8):1364-1371. DOI:10.1016/s0886-3350(02)01319-6

Wagner T, Knaflic D, Rauber M, Mester U. Influence of cataract surgery on the diabetic eye: A prospective study. Ger J Ophthalmol. 1996;5(2):79-83.

Phillips WB 2nd, Tasman WS. Postoperative endophthalmitis in association with diabetes mellitus. Ophthalmology. 1994;101(3):508-518.

Hykin PG, Gregson RM, Stevens JD, Hamilton PA. Extracapsular cataract extraction in proliferative diabetic retinopathy. Ophthalmology. 1993;100(3):394-399.

Ionides A, Dowler JG, Hykin PG, Rosen PH, Hamilton AM. Posterior capsule opacification following diabetic extracapsular cataract extraction. Eye (Lond). 1994;8(Pt5):535-537. DOI:10.1038/eye.1994.132

Ulbig MR, Hykin PG, Foss AJ, Schwartz SD, Hamilton PA. Anterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction in diabetic eyes. Am J Ophthalmol. 1993;115(3):321-326.

Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol. 1992;114(4):448-456. DOI:10.1016/s0002-9394(14)71857-4

Mittra RA, Borrillo JL, Dev S, Mieler WF, Koenig SB. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol. 2000;118(7):912-917.

Chung J, Kim MY, Kim HS, Yoo JS, Lee YC. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg. 2002;28(4):626-630.

Pollack A, Staurenghi G, Sager D, Mukesh B, Reiser H, Singh RP. Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy. Br J Ophthalmol. 2017;101(4):423-427. DOI:10.1136/bjophthalmol-2016-308617

Dowler JG, Sehmi KS, Hykin PG, Hamilton AM. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology. 1999;106(4):663-668.

Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol. 2002;240(9):735-738. DOI:10.1007/s00417-002-0530-7

Menchini U, Bandello F, Brancato R, Camesasca FI, Galdini M. Cystoid macular oedema after extracapsular cataract extraction and intraocular lens implantation in diabetic patients without retinopathy. Br J Ophthalmol. 1993;77(4):208-211. DOI:10.1136/bjo.77.4.208

Vignanelli M, Stucchi CA. Implants intraoculaires chez les patients diabétiques [Intraocular implants in diabetic patients]. J Fr Ophtalmol. 1987;10(3):219- 223.

Ostri C, Lund-Andersen H, Sander B, La Cour M. Phacoemulsification cataract surgery in a large cohort of diabetes patients: visual acuity outcomes and prognostic factors. J Cataract Refract Surg. 2011;37(11):2006-2012. DOI:10.1016/j.jcrs.2011.05.030